MCL

A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.

Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.

Due to the Thanksgiving holiday in the United States (recognized on Thursday, Nov. 23), Mayo Medical Laboratories’ specimen pickup and delivery schedule will be altered. To ensure that your specimen vitality and turnaround time are not affected, plan ahead and note that no pickups or deliveries will be made on Nov. 23 by our couriers or FedEx.

In October 2017, Mayo Medical Laboratories announced eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

This case presents an unusual colon polyp on an asymptomatic early 70 year-old male. At the time of screening colonoscopy, two small left colon polyps were noted and excised. What is the diagnosis?

Ann Moyer, M.D., Ph.D., discusses an additional gene, NUDT15, which is important in the prediction of thiopurine-related toxicity This gene has been added to our TPMT genotyping assay available through Mayo Medical Laboratories.

In September 2017, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

In the war against microbes, human beings are vastly outnumbered—and losing the weapons race.

In August 2017, Mayo Medical Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.

Ultimately, a pathologist has to commit to a diagnosis. Many trainees have difficulty committing to a diagnosis for fear of being wrong. Gary Keeney, M.D., Consultant in the Division of Anatomic Pathology at Mayo Clinic, provides a unique teaching approach with his cases, detailing the ancillary studies and discussing the differential diagnosis of the cases. View case #2.

Devin Oglesbee, Ph.D., Director of the Biochemical and Molecular Genetics Laboratories at Mayo Clinic, provides an overview of the lysosomal storage disease panel, when it is appropriate to order this test, what actions the results allow you to take, and how this test improves upon previous approaches.

Due to the Labor Day holiday, observed Monday, September 4, in the U.S., Mayo Medical Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround time are not affected, plan ahead, and note that no pickups or deliveries will be made on Sept. 4 by our couriers, FedEx, or UPS.

In this month’s “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to stratify a patient’s risk for prostate cancer and reduce unnecessary biopsies.